Evidence map›Paper›PMID 32943707›Full record

ArticleScientific reports2020

Tumor cells rely on the thiol oxidoreductase PDI for PERK signaling in order to survive ER stress.

Philip Kranz, Christopher Sänger, Alexandra Wolf, Jennifer Baumann, Eric Metzen, Melanie Baumann, Kirsten Göpelt, Ulf Brockmeier

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Philip KranzInstitut für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Christopher SängerInstitut für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Alexandra WolfInstitut für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Jennifer BaumannInstitut für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Eric MetzenInstitut für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Melanie BaumannInstitut für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Kirsten GöpeltInstitut für Physiologie, Universität Duisburg-Essen, Duisburg, Germany.
Ulf BrockmeierInstitut für Physiologie, Universität Duisburg-Essen, Duisburg, Germany. ulf.brockmeier@uni-due.de.
University of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Upon ER stress cells activate the unfolded protein response through PERK, IRE1 and ATF6. Remarkable effort has been made to delineate the downstream signaling of these three ER stress sensors after activation, but upstream regulation at the ER luminal site still remains mostly undefined. Here we report that the thiol oxidoreductase PDI is mandatory for activation of the PERK pathway in HEK293T as well as in human pancreatic, lung and colon cancer cells. Under ER stress, depletion of PDI selectively abrogated eIF2α phosphorylation, induction of ATF4, CHOP and even BiP. Furthermore, we could demonstrate that PDI prevented degradation of activated PERK by the 26S proteasome and therefore contributes to maintained PERK signaling. As a result of decreased PERK activity, PDI depleted cells showed an increased vulnerability to ER stress induced by chemicals or ionizing radiation in 2D as well as in 3D culture models. We conclude that PDI is an obligatory regulator of the PERK pathway with future therapy implications.

Indexed as

A549 CellsApoptosisCell LineCell Line, TumoreIF-2 KinaseEndoplasmic ReticulumEndoplasmic Reticulum StressHCT116 CellsHEK293 CellsHumansNeoplasmsOxidoreductasesPhosphorylationProteasome Endopeptidase ComplexProtein Disulfide-IsomerasesSignal TransductionEIF2AK3 protein, humaneIF-2 KinaseOxidoreductasesProteasome Endopeptidase ComplexProtein Disulfide-Isomerases

Identifiers

PMID32943707
PMCPMC7499200
OpenAlexW3087286916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.